Background Coronary computerized tomographic angiography (CTA) is being increasingly utilized in roles previously performed by cardiac catheterization, particularly for coronary artery imaging in low-risk patients with atypical symptoms or suspected…
Background Drug-coated balloons (DCBs) have shown efficacy for treatment of coronary artery disease. In the PEPCAD II ISR trial, paclitaxel-coated balloon (PCB) reduced in-stent restenosis (ISR) compared with paclitaxel-eluting stent…
Background Now it is not known which cell type is best for inducing therapeutic angiogenesis in end-stage critical limb ischemia (CLI). We hypothesized that mononuclear cells mobilized with granulocyte colony…
Aim The aim was to determine the prevalence and morphological characteristics of coronary artery ectasia (CAE) detected by 64-MSCT coronary angiography and to assess the clinical presentation, the association of…
A Clinical Endpoint Committee (CEC) is a panel of unbiased, third-party experts charged with centrally reviewing and classifying suspected endpoints, ascertaining whether they meet protocol definitions and providing standardized endpoint…
Introduction Dobutamine stress echocardiography is a valuable diagnostic imaging for differentiation between true and low flow–low gradient and pseudosevere aortic stenosis. Stroke volume, peak pressure gradient (PG) and mean pressure…
Introduction The Framingham Heart Study showed that patients with diabetes mellitus (DM) were 1.4–1.6 times more likely to develop atrial fibrillation (AF) and were at a twofold risk of having…
Background Vascular access site complications can follow diagnostic coronary and peripheral angiography and can be associated with significant morbidity. Vascular closure devices improve hemostasis at the access site and potentially…
Background Albeit several studies examined the association between cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) in heart failure (HF), results are still unclear and quite conflicting. Objective The objective…
Background Symptomatic recurrent mitral valve stenosis developed in 4% to 39% of patients after percutaneous mitral valvuloplasty (PMV). It is not known if these patients may benefit from repeat PMV….
